A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides

A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides

This study sought to develop a simple nanoparticle-based approach to enhance the efficiency and tolerability of lipopolysaccharide (LPS), a potent ligand of Toll-like Receptor 4 (TLR4), for immunotherapy in cancer. Despite holding promise within this context, the strong pro-inflammatory properties o...

Full description

Bibliographic Details
Main Authors: Maryam A. Shetab Boushehri, Mona M. A. Abdel-Mottaleb, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Drug Delivery
Subjects:
lipopolysaccharide (lps)
nanoparticles
pathogen-mimicking properties
localized necrosis
cancer immunotherapy
Online Access:http://dx.doi.org/10.1080/10717544.2018.1469684

Internet

http://dx.doi.org/10.1080/10717544.2018.1469684

Similar Items